Spots Global Cancer Trial Database for squamous cell carcinoma of the larynx
Every month we try and update this database with for squamous cell carcinoma of the larynx cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma | NCT03370276 | Squamous Cell C... Squamous Cell C... Squamous Cell C... Squamous Cell C... Squamous Cell C... Head and Neck S... Squamous Cell C... Head and Neck C... | Nivolumab Cetuximab | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer | NCT03114462 | Malignant Neopl... Squamous Cell C... | Stereotactic Hy... Questionnaires | 18 Years - | M.D. Anderson Cancer Center | |
HYpofractionateD RadioAblative (HYDRA) Treatment of Advanced Laryngeal Cancer | NCT02464137 | Squamous Cell C... | radiation | 18 Years - 99 Years | University of Texas Southwestern Medical Center | |
Safety Trial of IRESSA, Cisplatin and Radiation Therapy for Patients With Head and Neck Cancer | NCT00195078 | Head and Neck C... | ZD1839 (IRESSA) Cisplatin Radiation Thera... | 18 Years - | Weill Medical College of Cornell University | |
Phase 2 Trial of Maintenance Cemiplimab for Head and Neck Squamous Cell Carcinoma (HNSCC) | NCT04831450 | Head and Neck S... HNSCC Squamous Cell C... Squamous Cell C... Squamous Cell C... | Cemiplimab-Rwlc | 18 Years - | University of Miami | |
Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy | NCT01156142 | Head and Neck C... Mucositis Oral Complicati... Pain | doxepin hydroch... placebo | 18 Years - | Alliance for Clinical Trials in Oncology | |
De-Intensification of Postoperative Radiotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck | NCT06030440 | Squamous Cell C... Squamous Cell C... Squamous Cell C... Squamous Cell C... | Eliminating RT ... RT standard of ... | 18 Years - | University of Erlangen-Nürnberg Medical School | |
European Larynx Organ Preservation Study (ELOS) [MK-3475-C44] | NCT06137378 | Squamous Cell C... Hypopharyngeal ... Laryngeal Squam... Laryngeal Squam... Squamous Cell C... Squamous Cell C... Squamous Cell C... Squamous Cell C... Laryngeal Squam... Laryngectomy; S... Laryngeal Cance... Laryngeal Neopl... | KEYTRUDA® | 18 Years - 70 Years | University of Leipzig | |
Vorinostat in Combination With Chemoradiation in Locally Advanced HPV Negative HNSCC | NCT05608369 | HPV-Related Squ... Squamous Cell C... Squamous Cell C... Squamous Cell C... Squamous Cell C... | Cisplatin Radiation thera... Vorinostat | 18 Years - | Case Comprehensive Cancer Center | |
Testing the Safety of Giving a Standard Dose of Radiation Over a Shorter Period of Time for Patients Who Had Surgery for Intermediate-Risk Head and Neck Cancer | NCT05540899 | Head and Neck C... Head and Neck S... Squamous Cell C... Squamous Cell C... Squamous Cell C... | Hypofractionate... | 18 Years - 75 Years | American College of Radiology | |
Fluorescence-guided Surgery in Laryngeal- and Hypopharyngeal Cancer: a Feasibility Trial | NCT05752149 | Squamous Cell C... Squamous Cell C... | CRGD-ZW800-1 | 18 Years - | Erasmus Medical Center | |
Phase 2 Trial of Maintenance Cemiplimab for Head and Neck Squamous Cell Carcinoma (HNSCC) | NCT04831450 | Head and Neck S... HNSCC Squamous Cell C... Squamous Cell C... Squamous Cell C... | Cemiplimab-Rwlc | 18 Years - | University of Miami | |
De-Intensification of Postoperative Radiotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck | NCT06030440 | Squamous Cell C... Squamous Cell C... Squamous Cell C... Squamous Cell C... | Eliminating RT ... RT standard of ... | 18 Years - | University of Erlangen-Nürnberg Medical School | |
Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy | NCT01156142 | Head and Neck C... Mucositis Oral Complicati... Pain | doxepin hydroch... placebo | 18 Years - | Alliance for Clinical Trials in Oncology | |
Fluorescence-guided Surgery in Laryngeal- and Hypopharyngeal Cancer: a Feasibility Trial | NCT05752149 | Squamous Cell C... Squamous Cell C... | CRGD-ZW800-1 | 18 Years - | Erasmus Medical Center |